HIV-1 is the fifth leading cause of disability worldwide and the leading cause of morbidity in East and southern Africa. Recent clinical trials demonstrating the efficacy of antiretrovirals to prevent HIV-1 transmission have revolutionized the HIV-1 prevention field and provided the necessary components to make HIV-1 elimination potentially attainable. For HIV-1 serodiscordant couples, i.e. where one partner is HIV-1 infected and the other uninfected, the desire to have children often outweighs the HIV-1 transmission risk, and couples forgo condom use in order to satisfy their desired family size. We are currently conducting work in Kenya with HIV-1 serodiscordant couples to develop a coordinated, client-centered, evidence-based, risk-reduction "safer conception" intervention. Similar to approaches tested in Europe and suggested for couples in resource-limited settings, our combination approach includes: 1) antiretroviral therapy use by the HIV-1 infected partner, 2) pre- exposure prophylaxis use by the HIV-1 uninfected partner, 3) screening and treatment of genital tract infections in both partners, and 4) recommending unprotected sex only during peak fertility days of a woman's menstrual cycle (i.e. timed unprotected sex). Through formative work, however, we have identified an important gap in the feasibility of practicing timed unprotected sex that mHealth tools are perfectly suited to address. In this proposal, we aim to enhance our safer conception intervention by developing novel mHealth tools that will improve women's accuracy in identifying peak fertility periods and clinician-patient communication about safer conception and practicing timed unprotected sex. With an mHealth-experienced team of US and Kenyan HIV-1 prevention, reproductive health, and technology experts, we will 1) use simple message service (i.e. SMS or text message) surveys to determine fertility awareness methods that are most feasible for Kenyan women in HIV-1 serodiscordant partnerships to monitor, 2) develop an ovulation prediction algorithm and a safer conception tablet-based application that draws on SMS survey data to identify peak fertility days and feeds this prediction into individualized safer conception SMS messages and 3) pilot the novel mHealth tools, in combination with highly effective HIV-1 prevention strategies, among 40 HIV-1 serodiscordant couples with immediate fertility intentions to determine uptake and continued utilization of safer conception strategies and rates of condom use, pregnancy, and HIV-1 transmission. Our focus on improving the practice of timed unprotected sex is novel but fills a very important gap. While developed for HIV-1 serodiscordant couples in the Kenyan setting, each component could also be used by any African couples struggling with fertility complications. With our international, interdisciplinary team, we will additionally be able to build capacity among our local Kenyan research colleagues who have been managing mHealth projects for the past three years and are now poised to acquire new skills in application design, development and testing, and become leaders in mHealth research in Kenya.

Public Health Relevance

Couples in which one member is HIV-infected and the other HIV-uninfected (i.e., HIV discordant couples) need strategies to reduce the risk of HIV transmission when they attempt to conceive children. Building on our current work to develop a client-centered, evidence-based safer conception intervention, the current proposal will enhance that intervention with mHealth components: SMS (i.e. text message) surveys to capture data on fertility signs and feed into an ovulation prediction algorithm, a tablet-based application to facilitate in-clinic counseling sessions assessing couple readiness to practice timed unprotected sex (an important but often difficult component of safer conception), and SMS safer conception HIV prevention messages for couples based on their individual predicted upcoming days with peak fertility. With approximately 50% of HIV-infected people estimated to have a stable, HIV-uninfected partner and high rates of pregnancy and fertility intentions among African couples, this work is extremely important and will have great public health significance.

Agency
National Institute of Health (NIH)
Institute
Fogarty International Center (FIC)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21TW009908-01
Application #
8806409
Study Section
Special Emphasis Panel (ZRG1-IMST-K (50))
Program Officer
Povlich, Laura
Project Start
2014-09-10
Project End
2016-04-30
Budget Start
2014-09-10
Budget End
2015-04-30
Support Year
1
Fiscal Year
2014
Total Cost
$178,777
Indirect Cost
$50,320
Name
University of Washington
Department
Public Health & Prev Medicine
Type
Schools of Medicine
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195